Abstract
Among all the possible methods of creating optically active compounds, enantioselective catalysis using chiral transition metal complexes is the most effective methods since a small amount of chiral material can, in principle, produce a large amount of optically active product. The enantioselective hydrogenation of prochiral C=C and C=X (X=N,O) double bonds constitutes a powerful technology to establish chirality at stereogenic carbon atoms. This tool has enabled the chemist to compete successfully with nature in the creation of enantiomerically pure compounds. The Rh(I) complexes bearing chiral tertiary phosphines are remarkable catalysts in the hydrogenation of dehydroamino acids1,2,3,4. Optimisation of the conditions made it possible for the industrial production of several amino acids5. In spite of such impressive achievments and improvments in the design of new ligands for rhodium(I) catalysts , the scope of asymmetric hydrogenation is not so wide. A breakthrough came by the discovery of hexacoordinated ruthenium catalysts containing the highly effective axially symmetric BINAP ligand 7,8 . A disguishing feature of theses catalysts is their universality, they are suitable for enantioselective hydrogenation of wide range of substrates9. In the application of such technology to the synthesis optically active compounds in perfumery, food industry and drugs research, chemists are facing the task of designing broad libraries of chiral catalysts. Therefore developments of chemistry which allows preparation of wide range of chiral ruthenium catalysts is highly desirable for a rapid screening. As part of our research programm we have initiated and developed a novel and general route for the preparation of chiral ruthenium (II) catalysts. Such chemistry and the usefulness of these catalysts will be briefly presented with the successful development of enantioselective hydrogenation of prochiral substrates including olefins and functionalized ketones. Moreover, several applications in the synthesis of various complex biologically active molecules will be reported.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
K.E. Koenig in Asymmetric Catalysis, J.E. Morrison, Ed. Academic Press, New York, Vol.5 (1985).
H. Takaya, T. Ohta and R. Noyori Catalytic Asymmetric Synthesis, I. Ojima, ed., Chapter 1, VCH publisher, New York (1993).
R. Noyori Asymmetrie Catalysis in Organic Synthesis, Chapter 2, p. 16, J. Wiley, New York (1994).
J.P. Genet Advanced Asymmetric Synthesis, Chapter 8, G.R. Stephenson, Ed., p. 146, Chapman and Hall, London (1996).
H.B. Kagan, Bull. Soc. Chim. Fr., 846, (1988).
K. Inogushi, S. Sakuraba and K. Achiwa Synlett, 169, (1992).
T. Ikariya, I. Ishii, H. Kawano, T. Arai, M. Saburi, S. Yoshikawa and S. Akutagawa J. Chem. Soc. Chenu Commun., 922, (1985).
R. Noyori, M. Ohta, Y. Hsiao, M. Kitamura, H. Takaya J. Am. Chem. Soc., 108, 7117, (1986).
Reviews: a) R. Noyori Chem. Soc. Review, 18, 2, 187, (1989); b) R. Noyori Science, 248, 1194, (1990); c) R. Noyori and H. Takaya Acc. Chem. Res., 23, 345, (1990); d) H. Takaya, T. Ohta, K. Mashima and R. Noyori Pure Appl. Chem., 62, 1135, (1990); e) R. Noyori Tetrahedron, 50, 4259, (1994); f) R. Noyori and S. Hashiguchi Acc. Chem. Res., 30, 97, (1997).
T. Ohta, Y. Tonomura, K. Nozaki, H. Takaya, K. Mashima Organometallics, 15, 6, 1521, (1996).
T. Ohta, H. Takaya, R. Noyori Inorg. Chem. 27, 566, (1988).
Review: J.P. Genet in Reduction Organic Synthesis, Am. Chem. Soc. Symposium Series 641, Abdel F. Magid, ed., Chapter 2, 31, (1996).
J.P. Genet, S. Mallart, C. Pinel, S. Jugé and J.A. Laffitte Tetrahedron: Asymmetry, 2, 43, (1991); b) J.P. Genet, S. Mallart, C. Pinel, S. Thorimbert, S. Jugé, J.A. Laffitte Tetrahedron: Asymmetry, 555, (1991).
J.P. Genet, C. Pinel, S. Mallart, S. Jugé, N. Cailhol and J.A. Laffitte Tetrahedron Lett., 33, 5343, (1992).
J.P. Genet, C. Pinel, V. Ratovelomanana-Vidal, S. Mallart, X. Pfister, M.C.Caño de Andrade, J.A. Laffitte Tetrahedron: Asymmetry, 5, 665, (1994).
J.P. Genet, V. Ratovelomanana-Vidal, X. Pfister, M.C.Caño de Andrade, J.A. Laffitte, S. Darses, C. Pinel, L. Bischoff, C. Galopin Tetrahedron: Asymmetry, 5, 675, (1994).
M. Burk, T. P. Harper and C.S. Kalberg J. Am. Chem. Soc., 117, 4423, (1995).
D. Blanc, J.C. Henry, V. Ratovelomanana-Vidal and J.P. Genet Tetrahedron Lett., 38, 6603, (1997).
J.P. Genet, V. Ratovelomanana-Vidal unpublished results.
J.C. Henry, D. Lavergne, V. Ratovelomanana-Vidal, J.P. Genet, T.M. Dolgina, I.P. Beletskaya Tetrahedron Lett., 39, 3473 (1998).
Pfizer, Sandwich Drug Discoveries (October 1997)
J. Lastenet, S. Coulon, S. Roussiasse, M. Bulliard, B. Laboue PPG SIPSY, (1997).
S. Roland, Ph.D. Thesis Pierre and Marie Curie University(1995)
J.P. Genet, J.C. Galland, unpublished results.
H. Takaya, T. Ohta, N. Sayo, H. Kumobayashi, S. Akutagaria, S. Inoue, I. Kasahara, R. Noyori, J. Am. Chem. Soc., 109, 1596 (1987).
I. Gautier, V. Ratovelomanana-Vidal, P. Savignac, J.P. Genet Tetrahedron Lett., 37, 7721, (1996).
J.P. Tranchier, V. Ratovelomanana-Vidal, J.P. Genet, S. Tong, T. Cohen Tetrahedron Lett., 38, 2951,(1997).
J.P. Genet, V. Ratovelomanana-Vidal, M.C. Caño de Andrade, X. Pfister, P. Guerreiro, J.Y. Lenoir Tetrahedron Lett., 36, 4801, (1995).
P. Guerreiro, P. Bertus, V. Ratovelomanana-Vidal, J.P. Genet unpublished results.
E. Coulon, S. Duprat de Paule, V. Ratovelomanana-Vidal, M.C. Caño de Andrade, J.P. Genet unpublished results.
J.P. Genet, M.C. Caño de Andrade, V. Ratovelomanana-Vidal Tetrahedron Lett., 36, 2663, (1995).
M.C. Caño de Andrade, V. Ratovelomanana-Vidal, unpublished results.
A. Girard, C. Greek, D. Ferroud, J.P. Genet Tetrahedron Lett., 37, 7967, (1997).
Review: C. Greek, J.P. Genet Synlett, 741, (1997).
C. Greek, L. Bischoff, J.P. Genet Tetrahedron: Asymmetry, 6, 1989, (1995).
C. Greek, F. Ferreira, J.P. Genet Tetrahedron Lett., 37, 203, (1996); b) F. Ferreira, C. Greek, J.P. Genet Bull. Soc. Chim. Fr., 134, 615, (1997).
For some other developments of this chemistry with industrial perspectives see review: R. Schmidt, E.A. Broger, M. Cereghetti, Y. Crameri, J. Foricher, M. Lalonde, R.K. Müller, M. Scalone, G. Schoettlel, U. Zutter Pure & Appl. Chem., 68, 1, 131 (1996).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Genet, J.P. (1999). Recent Developments in Asymmetric Hydrogenation with Chiral Ru(II) Catalysts and Synthetic Applications to Biologically Active Molecules. In: Scolastico, C., Nicotra, F. (eds) Current Trends in Organic Synthesis. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4801-0_29
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4801-0_29
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7175-5
Online ISBN: 978-1-4615-4801-0
eBook Packages: Springer Book Archive